{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T05:00:51Z","timestamp":1773810051416,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.leukres.2020.106463","type":"journal-article","created":{"date-parts":[[2020,10,18]],"date-time":"2020-10-18T09:45:01Z","timestamp":1603014301000},"page":"106463","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Vancomycin-resistant enterococci infection and predisposing factors for infection and mortality in patients with acute leukaemia and febrile neutropenia"],"prefix":"10.1016","volume":"99","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1361-6213","authenticated-orcid":false,"given":"Tugcan Alp","family":"Kirkizlar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Halis","family":"Akalin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Onur","family":"Kirkizlar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fahir","family":"Ozkalemkas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vildan","family":"Ozkocaman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esra","family":"Kazak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cuneyt","family":"Ozakin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esra Nur","family":"Bulbul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ezgi Sezen","family":"Ozboz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R\u0131dvan","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"43","key":"10.1016\/j.leukres.2020.106463_bib0005","first-page":"725","article-title":"Control of the spread of vancomycin-resistant Enterococci in hospitals. Epidemiology and clinical relevance","volume":"110","author":"Mutters","year":"2013","journal-title":"Dtsch Arztebl Int."},{"issue":"1","key":"10.1016\/j.leukres.2020.106463_bib0010","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1017\/ice.2015.228","article-title":"VRE and VSE bacteremia outcomes in the era of effective VRE therapy: a systematic review and meta-analysis","volume":"37","author":"Prematunge","year":"2016","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"10.1016\/j.leukres.2020.106463_bib0015","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ijid.2016.11.005","article-title":"The risk factors, costs, and survival analysis of invasive VRE infections at a medical center in Eastern in Taiwan","volume":"54","author":"Jiang","year":"2017","journal-title":"Int. J. Infect. Dis."},{"issue":"4","key":"10.1016\/j.leukres.2020.106463_bib0020","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1086\/427512","article-title":"Impact of vancomycin resistance on mortality among patients with neutropenia and enterococcal bloodstream infection","volume":"191","author":"Diaz Granados","year":"2005","journal-title":"J. Infect. Dis."},{"issue":"3","key":"10.1016\/j.leukres.2020.106463_bib0025","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1600-0609.2007.00911.x","article-title":"Vancomycin-resistant Enterococcus faecium infection in patients with hematologic malignancy: patients with acute myeloid leukemia are at high-risk","volume":"79","author":"Worth","year":"2007","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.leukres.2020.106463_bib0030","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1186\/1471-2334-13-504","article-title":"Impact of vancomycin resistance on mortality neutropenic patients with enterococcal bloodstream infection: a retrospective study","volume":"13","author":"Cho","year":"2013","journal-title":"BMC Infect. Dis."},{"issue":"12","key":"10.1016\/j.leukres.2020.106463_bib0035","first-page":"1969","article-title":"Outcomes of therapy: vancomycin-resistant enterococcal bacteremia in hematology and bone marrow transplant patients","volume":"19","author":"Kraft","year":"2011","journal-title":"Support. Care Cancer"},{"issue":"2","key":"10.1016\/j.leukres.2020.106463_bib0040","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1128\/AAC.01289-13","article-title":"Systematic review and meta-analysis of linezolid versus daptomycin for treatment of vancomycin-resistant enterococcal bacteremia","volume":"58","author":"Balli","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.leukres.2020.106463_bib0045","series-title":"22nd Informational Supplement. M100-S22","article-title":"Performance standards for antimicrobial testing","author":"Clinical and Laboratory Standards Institute","year":"2012"},{"issue":"4","key":"10.1016\/j.leukres.2020.106463_bib0050","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/cid\/cir073","article-title":"Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of America","volume":"52","author":"Freifeld","year":"2011","journal-title":"Clin. Infect. Dis."},{"issue":"2","key":"10.1016\/j.leukres.2020.106463_bib0055","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0196-6553(95)90104-3","article-title":"Centers for Disease Control and Prevention Recommendations for preventing the spread of vancomycin resistance: recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC)","volume":"23","year":"1995","journal-title":"Am. J. Infect. Control"},{"issue":"9","key":"10.1016\/j.leukres.2020.106463_bib0060","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/cid\/cir257","article-title":"And the Healthcare Infection Control Pactices Advisory Committee (HICPAC). Guidelines for the prevention of intravascular catheter-related infections","volume":"52","author":"O\u2019Grady","year":"2011","journal-title":"Clin. Infect. Dis."},{"issue":"1","key":"10.1016\/j.leukres.2020.106463_bib0065","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/cc11454","article-title":"KDIGO AKI Guideline Work Group. Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1)","volume":"17","author":"Kellum","year":"2013","journal-title":"Crit. Care"},{"key":"10.1016\/j.leukres.2020.106463_bib0070","series-title":"Definitions, Sources and Methods. Surgical Procedures by ICD-9-CM","author":"OECD Health Data","year":"2012"},{"issue":"5","key":"10.1016\/j.leukres.2020.106463_bib0075","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1086\/587647","article-title":"Risk of vancomycin-resistant Enterococcus (VRE) bloodstream infection among patients colonized with VRE","volume":"29","author":"Olivier","year":"2008","journal-title":"Infect. Control Hosp. Epidemiol."},{"issue":"5","key":"10.1016\/j.leukres.2020.106463_bib0080","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.bbmt.2007.01.078","article-title":"Colonization, bloodstream infection, and mortality caused by vancomycin-resistant enterococcus early after allogeneic hematopoietic stem cell transplant","volume":"13","author":"Weinstock","year":"2007","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"2","key":"10.1016\/j.leukres.2020.106463_bib0085","first-page":"231","article-title":"Incidence of vancomycin-resistant enterococci (VRE) infection in high-risk febrile neutropenic patients colonized with VRE","volume":"19","author":"Bossaer","year":"2010","journal-title":"Support. Care Cancer"},{"issue":"7214","key":"10.1016\/j.leukres.2020.106463_bib0090","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/nature07250","article-title":"Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits","volume":"455","author":"Brandl","year":"2008","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.leukres.2020.106463_bib0095","first-page":"605","article-title":"Implications of treatment-induced mucosal barrier injury","volume":"17","author":"Blijlevens","year":"2005","journal-title":"Curr. Opin. Oncol."},{"issue":"9","key":"10.1016\/j.leukres.2020.106463_bib0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0075658","article-title":"Trends and significance of VRE colonization in the ICU: a meta-analysis of published studies","volume":"8","author":"Ziakas","year":"2013","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.leukres.2020.106463_bib0105","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1086\/342904","article-title":"Risk factors for development of vancomycin-resistant enterococcal bloodstream infection in patients with cancer who are colonized with vancomycin-resistant enterococci","volume":"35","author":"Zaas","year":"2002","journal-title":"Clin. Infect. Dis."},{"issue":"11","key":"10.1016\/j.leukres.2020.106463_bib0110","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1080\/10428194.2017.1306645","article-title":"Vancomycin-resistant enterococci in acute myeloid leukemia and myelodisplastic syndrome patients undergoing induction chemotherapy with idarubicin and cytarabine","volume":"58","author":"Heisel","year":"2017","journal-title":"Leuk. Lymphoma"},{"issue":"8","key":"10.1016\/j.leukres.2020.106463_bib0115","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.ajic.2006.04.205","article-title":"Colonization and infection with vancomycin-resistant Enterococcus among patients with cancer","volume":"34","author":"Matar","year":"2006","journal-title":"Am. J. Infect. Control"},{"issue":"9","key":"10.1016\/j.leukres.2020.106463_bib0120","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.3855\/jidc.4451","article-title":"Vancomycin-resistant enterococci colonization and bacteremia in patients with hematological malignancies","volume":"8","author":"Gedik","year":"2014","journal-title":"J. Infect. Dev."},{"issue":"1","key":"10.1016\/j.leukres.2020.106463_bib0125","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1017\/ice.2014.3","article-title":"Frequency, risk factors, and outcomes of vancomycin-resistant Enterococcus colonization and infection in patients with newly diagnosed acute leukemia: different patterns in patients with acute myelogenous and acute lymphoblastic leukemia","volume":"36","author":"Ford","year":"2015","journal-title":"Infect. Control Hosp. Epidemiol."},{"issue":"8","key":"10.1016\/j.leukres.2020.106463_bib0130","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1086\/518971","article-title":"A population-based investigation of invasive vancomycin-resistant Enterococcus infection in Metropolitan Atlanta, georgia, and predictors of mortality","volume":"28","author":"Camins","year":"2007","journal-title":"Infect. Control Hosp. Epidemiol."},{"issue":"4","key":"10.1016\/j.leukres.2020.106463_bib0135","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1046\/j.0007-1048.2002.03339.x","article-title":"Outbreak of vancomycin-resistant Enterococcus faecium in a hematology unit: risk factor assessment and succesful control of the epidemic","volume":"116","author":"Timmers","year":"2002","journal-title":"Br. J. Haematol."},{"issue":"10","key":"10.1016\/j.leukres.2020.106463_bib0140","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1086\/501561","article-title":"Association between mucositis severity and vancomycin-resistant enterococcal bloodstream infection in hospitalized cancer patients","volume":"20","author":"Kuehnert","year":"1999","journal-title":"Infect. Control Hosp. Epidemiol."},{"issue":"5","key":"10.1016\/j.leukres.2020.106463_bib0145","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/tid.12120","article-title":"Evaluation of risk factors for vancomycin resistant Enterococcus bacteremia among previously colonized hematopoietic stem cell transplant patients","volume":"15","author":"Kang","year":"2013","journal-title":"Transpl. Infect. Dis."},{"issue":"Suppl 1","key":"10.1016\/j.leukres.2020.106463_bib0150","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1093\/ofid\/ofx163.647","article-title":"Risk Factors and outcomes of vancomycin-resistant vs. Vancomycin-sensitive enterococcal blood stream infections in patients with acute myeloid leukemia","volume":"4","author":"Addisu","year":"2017","journal-title":"Open Forum Infect. Dis."},{"issue":"3","key":"10.1016\/j.leukres.2020.106463_bib0155","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ijantimicag.2016.11.009","article-title":"Clinical and microbiological characteristics of bloodstream infections among patients with haematological malignancies with and without neutropenia at a medical centre in northern Taiwan, 2008-2013","volume":"49","author":"Chen","year":"2017","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"3","key":"10.1016\/j.leukres.2020.106463_bib0160","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1086\/430909","article-title":"Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: a meta-analysis","volume":"41","author":"DiazGranados","year":"2005","journal-title":"Clin. Infect. Dis."},{"issue":"6","key":"10.1016\/j.leukres.2020.106463_bib0165","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1093\/cid\/civ444","article-title":"Comparison of the effectiveness and safety of linezolid and daptomycin in vancomycin-resistant enterococcal bloodstream infection: a national cohort study of veterans affairs patients","volume":"61","author":"Britt","year":"2015","journal-title":"Clin. Infect. Dis."},{"issue":"6","key":"10.1016\/j.leukres.2020.106463_bib0170","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ijantimicag.2008.12.007","article-title":"Daptomycin for the treatment of enterococcal bacteraemia: results from the Cubicin Outcomes Registry and Experience (CORE)","volume":"33","author":"Mohr","year":"2009","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"Suppl 1","key":"10.1016\/j.leukres.2020.106463_bib0175","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/ofid\/ofx163.648","article-title":"Retrospective study of linezolid vs. Daptomycin for the treatment of vancomycin-resistant Enterococcal bloodstream infection","volume":"4","author":"Rai","year":"2017","journal-title":"Open Forum Infect. Dis."}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212620301685?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212620301685?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T01:00:43Z","timestamp":1758934843000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212620301685"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":35,"alternative-id":["S0145212620301685"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2020.106463","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vancomycin-resistant enterococci infection and predisposing factors for infection and mortality in patients with acute leukaemia and febrile neutropenia","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2020.106463","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106463"}}